Dendritic cells can initiate protective immune responses against malaria

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 5173-5176

  Bruna Romero O ^a   Rodriguez, A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MALARIA VACCINE; SPOROZOITE VACCINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; MALARIA; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; INTERFERON TYPE II; MALARIA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM YOELII;

EID: 0034912433     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.5173-5176.2001     Document Type: Article

References (30)

1. Immunobiology of dendritic cells
2. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered fas-mediated apoptosis
3. Immunization of man against sporozite-induced falciparum malaria
4. DNA-based immunization by in vivo transfection of dendritic cells
5. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge
6. DNA vaccination as an approach to malaria control: Current status and strategies
7. Delivery of protein antigens and DNA by virulence-attenuated strains of salmonella typhimurium and listeria monocytogenes
8. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii
9. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
10. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes
11. Antigen processing for amateurs and professionals
12. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism
13. Quantification of antigen specific CD8+ T cells using an ELISPOT assay
14. Preerythrocytic malaria vaccine: Mechanisms of protective immunity and human vaccine trials
15. Malaria vaccines: Multiple targets
16. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei
17. The prime-boost strategy: Exciting prospects for improved vaccination
18. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria
19. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity
20. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria
21. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria
22. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites
23. Vaccines against intracellular infections requiring cellular immunity
24. B cells solicit their own help from T cells
25. Genetic immunization is a simple method for eliciting an immune response
26. Heterologous protection against influenza by injection of DNA encoding a viral protein
27. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine
28. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites
29. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
30. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines